BlackRock Investment Management, LLC - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 45 filers reported holding PROTEON THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$3,000
-76.9%
1,3660.0%0.00%
Q3 2016$13,000
+18.2%
1,3660.0%0.00%
Q2 2016$11,000
-94.5%
1,366
-94.7%
0.00%
Q1 2016$201,000
-49.2%
26,004
+1.8%
0.00%
-100.0%
Q4 2015$396,000
+12.2%
25,533
+0.7%
0.00%
Q3 2015$353,000
-23.4%
25,365
-1.8%
0.00%
-100.0%
Q2 2015$461,000
+3446.2%
25,835
+2156.3%
0.00%
Q1 2015$13,000
+8.3%
1,145
-0.4%
0.00%
Q4 2014$12,0001,1500.00%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$27,423,00016.02%
Monashee Investment Management LLC 77,102$1,072,0007.40%
Deer VII & Co. Ltd. 315,101$4,383,0004.15%
RA Capital Management 1,506,872$20,961,0003.01%
MPM ASSET MANAGEMENT LLC 983,381$13,679,0002.10%
Omega Fund Management, LLC 250,000$3,478,0001.96%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,343$17,601,0000.68%
Perceptive Advisors 550,000$7,650,0000.31%
TIVERTON ASSET MANAGEMENT LLC 375,000$5,216,0000.12%
Baker Brothers Advisors 274,617$3,820,0000.04%
View complete list of PROTEON THERAPEUTICS INC shareholders